Stoke Therapeutics (STOK) Profit After Tax (2018 - 2026)
Stoke Therapeutics' quarterly Profit After Tax came in at -$50.0 million in Q1 2026, down 144.3% year-on-year from $112.9 million in Q1 2025, and up 13.69% quarter-over-quarter from -$57.9 million in Q4 2025.
Stoke Therapeutics has reported Profit After Tax for 9 years, with the latest figure at -$50.0 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 144.3% year-over-year to -$50.0 million; the trailing twelve-month figure through Mar 2026 stood at -$169.8 million (down 437.7% YoY), and the FY2025 full-year result was -$6.9 million, up 92.26% from the prior year.
- Profit After Tax for Q1 2026 stood at -$50.0 million, up from -$57.9 million in the prior quarter.
- The five-year high for Profit After Tax was $112.9 million in Q1 2025, with the low at -$57.9 million in Q4 2025.
- Average Profit After Tax over 5 years is -$20.7 million, with a median of -$25.7 million recorded in 2024.
- Peak annual rise in Profit After Tax reached 527.99% in 2025, while the deepest fall reached 452.7% in 2025.
- Tracing STOK's Profit After Tax over 5 years: stood at -$25.7 million in 2022, then dropped by 5.08% to -$27.0 million in 2023, then jumped by 61.12% to -$10.5 million in 2024, then slumped by 452.7% to -$57.9 million in 2025, then gained by 13.69% to -$50.0 million in 2026.
- The last three Profit After Tax figures came in at -$50.0 million (Q1 2026), -$57.9 million (Q4 2025), and -$38.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Stoke Therapeutics | 1.92 Bn | 1.92 Bn | - | -50.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.00 Mn |
| Dec 31, 2025 | -57.93 Mn |
| Sep 30, 2025 | -38.35 Mn |
| Jun 30, 2025 | -23.48 Mn |
| Mar 31, 2025 | 112.88 Mn |
| Dec 31, 2024 | -10.48 Mn |
| Sep 30, 2024 | -26.43 Mn |
| Jun 30, 2024 | -25.70 Mn |
| Mar 31, 2024 | -26.37 Mn |
| Dec 31, 2023 | -26.96 Mn |
| Sep 30, 2023 | -24.54 Mn |
| Jun 30, 2023 | -30.65 Mn |
| Mar 31, 2023 | -22.55 Mn |
| Dec 31, 2022 | -25.66 Mn |
| Sep 30, 2022 | -26.11 Mn |
| Jun 30, 2022 | -24.65 Mn |
| Mar 31, 2022 | -24.65 Mn |
| Dec 31, 2021 | -24.45 Mn |
| Sep 30, 2021 | -22.60 Mn |
| Jun 30, 2021 | -21.97 Mn |
| Mar 31, 2021 | -16.79 Mn |
| Dec 31, 2020 | -14.56 Mn |
| Sep 30, 2020 | -13.68 Mn |
| Jun 30, 2020 | -12.96 Mn |
| Mar 31, 2020 | -11.04 Mn |
| Dec 31, 2019 | -10.16 Mn |
| Sep 30, 2019 | -8.60 Mn |
| Jun 30, 2019 | -7.82 Mn |
| Mar 31, 2019 | -5.74 Mn |
| Dec 31, 2018 | -4.28 Mn |
| Sep 30, 2018 | -3.32 Mn |
| Jun 30, 2018 | -3.01 Mn |